Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2506) — Hamilton, Ontario

Public research footprint of Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2506), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Small Cell Lung Cancer · Carcinoma, Renal Cell · Squamous Cell Carcinoma of Head and Neck · Non-small Cell Lung Cancer

Recently updated registry entries

NCT05171647 — A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab… (Active Not Recruiting)
NCT05153239 — Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus… (Completed)
NCT06459180 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2506)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.